Having a higher blast percentage in circulation than bone marrow: Clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias

Leukemia

Volumn 19, Issue 9, 2005, Pages 1567-1572

  Amin, H M ^a   Yang, Y ^a   Shen, Y ^a   Estey, E H ^a   Giles, F J ^a   Pierce, S A ^a   Kantarjian, H M ^a   O'Brien, S M ^a   Jilani, I ^b   Albitar, M ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Acute leukemia; Blasts; Myelodysplastic syndrome; Survival

Indexed keywords

CYTARABINE; FLUDARABINE; IDARUBICIN; TOPOTECAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW CELL; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME ANALYSIS; CLINICAL STUDY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROME; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; ACUTE DISEASE; BLAST CELL CRISIS; BLOOD; BONE MARROW; CHILD; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; LYMPHATIC LEUKEMIA; MALE; MIDDLE AGED; MYELOID LEUKEMIA; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL; VASCULARIZATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLAST CRISIS; BONE MARROW; CHILD; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYELODYSPLASTIC SYNDROMES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 26944439771     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2403876     Document Type: Article

References (14)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 1976; 33: 451-458.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985; 103: 620-625.
3. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
4. Brunning RD, Bennett JM, Flandrin G, Flandrin G, Matutes E, Head D et al. Myelodysplastic syndromes: Introduction. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2001, pp 63-67.
5. Griffin TC, Shuster JJ, Buchanan GR, Murphy SB, Camitta BM, Amylon MD. Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: A Pediatric Oncology Group study. Leukemia 2000; 14: 792-795.
6. Vehmeyer K, Haase D, Alves F. Increased peripheral stem cell pool in MDS: An indicator of disease progression? Leuk Res 2001; 25: 955-959.
7. Berer A, Jager E, Sagaster V, Streubel B, Wizamal F, Sperr WR et al. Circulating myeloid colony-forming cells predict survival in myelodysplastic syndromes. Ann Hematol 2003; 82: 271-277.
8. Verstovsek S, Kantarjian H, Aguayo A, Manshouri T, Freireich E, Keating M et al. Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome. Br J Haematol 2001; 114: 290-295.
9. Aref S, Mabed M, Sakrana M, Goda M, El-Sherbiny M. Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: Relationship to disease characteristics. Hematology 2002; 7: 273-279.
10. Recher C, Ysebaert L, Beyne-Rauzy O, Mansat-De Mas V, Ruidavets JB, Cariven P et al. Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis. Cancer Res 2004; 64: 3191-3197.
11. Thomas X, Anglaret B, Bailly M, Maritaz O, Magaud JP, Archimbaud E. Differential adhesiveness between blood and marrow leukemic cells having similar pattern of VLA adhesion molecule expression. Leuk Res 1998; 22: 953-960.
12. Bradstock KF, Gottlieb DJ. Interaction of acute leukemia cells with the bone marrow microenvironment: Implications for control of minimal residual disease. Lymphoma 1995; 18: 1-16.
13. Voermans C, van Heese WP, de Jong I, Gerritsen WR, van Der Schoot CE. Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia 2002; 16: 650-657.
14. Greenberg P, Anderson J, de Witte T, Estey E, Fenaux P, Gupta P et al. Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group. J Clin Oncol 2000; 18: 3447-3452.